Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden | Blood Cancer Journal
Diffuse Large B-Cell Lymphoma (DLBCL): Practice Essentials, Background, Pathophysiology
Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular
Analysis of Growth in the Diffuse Large B-Cell Lymphoma Treatment Market: Forecasting Demand, Trends, and
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
The overall survival of in diffuse large B‐cell lymphoma (DLBCL)... | Download Scientific Diagram
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images | Scientific Reports
Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA | Future Oncology
Diffuse Large B-cell Lymphoma: Symptoms, Treatment and Prognosis: 9781634844024: Medicine & Health Science Books @ Amazon.com
DLBCL Prognosis: Fear, Hope, and Understanding Survival Rates | MyLymphomaTeam
British Journal of Haematology | Wiley Online Library
Overall survival (OS) in all 75 patients with diffuse large B-cell... | Download Scientific Diagram
Blood Journal on X: "Limited-stage diffuse large B-cell lymphoma https://t.co/ujdkUK6IrM https://t.co/MjOVxXrUGq" / X
Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram
Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy | NEJM
Frontiers | Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
Evolution of therapy for limited stage diffuse large B-cell lymphoma | Blood Cancer Journal
Diffuse Large B-cell Lymphoma (DLBCL) - Lymphoma Australia
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
A) Overall survival of 112 patients with relapsed diffuse large B-cell... | Download Scientific Diagram
